Life Sciences

As Rob Atkinson writes for The Hill, price controls and other steps to reduce drug company revenues would stifle knowledge generation and sharing, leaving future generations less access to effective new drugs than would otherwise be the case.
Life Sciences
Check a box to narrow search for individual content items that cover numerous issues.
November 10, 2018
As Rob Atkinson writes for The Hill, price controls and other steps to reduce drug company revenues would stifle knowledge generation and sharing, leaving future generations less access to effective new drugs than would otherwise be the case.
November 5, 2018
A considerable share of biopharma research “spills over” and contributes to knowledge discovery and drug development overall, not just in individual firms’ labs.
September 24, 2018
The Non-GMO Project food label deliberately deceives and misleads consumers in violation of the Federal Food, Drug and Cosmetic Act. ITIF petitions FDA to prohibit such labels.
September 13, 2018
ITIF's Center for Data Innovation will host a public forum with key stakeholders from government, the private sector, and academia to discuss the latest developments in using data to improve health care outcomes, reduce health care costs, and empower patients.
August 24, 2018
A contagion of poor public policy is sweeping across Latin America in the form of the spreading use of compulsory licenses on novel pharmaceutical drugs, and it threatens to undermine the very ecosystem supporting the development of medicines designed to treat deadly diseases in the first place.
June 28, 2018
As ITIF’s Stephen Ezell and Richard Owens of the Macdonald Laurier Institute write for the Financial Post, free-riding on drug prices is an example of how Canada refuses to step up to what is required for a globally leading innovation culture.
June 18, 2018
If drug price controls were lifted throughout the OECD, the number of new treatments available would increase 8 to 13 new drug compounds by 2030, writes John Wu in Innovation Files.
May 9, 2018
Please join ITIF for an event discussing needed policies to ensure sustained U.S. life-sciences leadership.
May 7, 2018
Any effective U.S. life-sciences innovation policy needs to level the global playing field by taking more forceful action to address unfair trade practices, Joe Kennedy writes for Stat News.
April 30, 2018
Intellectual property rights go a long way to helping transform clever ideas into life-saving products that address global health challenges, ITIF’s Stephen Ezell and Mark Schultz of the Southern Illinois University School of Law write for Brink News.

Pages